Wood E, Kerr T, Montaner J, Strathdee SA, Wodak A, Hankins CA, Schechter MT, Tyndall MW Rationale for evaluating North America's first medically supervised safer-injecting facility Lancet Infectious Diseases PubMed
Wood E, Kerr T, Montaner J, Strathdee SA, Wodak A, Hankins CA, Schechter MT, Tyndall MW Rationale for evaluating North America's first medically supervised safer-injecting facility Lancet Infectious Diseases PubMed